Trailing-twelve-month (TTM) revenue is $399.51 Million. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $180,671,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-12 |
| Q4 FY2025Period ended 2025-12-31 | $103,422,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-20 |
| Q1 FY2026Period ended 2026-03-31 | $72,660,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-29 |
| Q2 FY2026Period ended 2026-06-30 | $42,760,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-17 |
| TTM revenue | $399,513,000 |
Current P/S: $248,629,370 market capitalization ÷ $399,513,000 TTM revenue = 0.62x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T13:43:33.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $42.76M.
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 13 comparable quarters.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T13:46:51.931Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|
| Africa | N/A | N/A | $159M |
| Asia | $31M | $94M | $108M |
| Europe | $47M | $41M | $3M |
| North America | $99M | $156M | $64M |
$399.51M
$399.51 Million
N/A
+229.68%
5 Year compound annual growth rate
1 Year
N/A
3 Year
+19.80%
5 Year
+229.68%
10 Year
N/A
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $477.53M | +$14.20M | +3.07% |
| 2024 | $463.33M | +$179.22M | +63.08% |
| 2023 | $284.11M | +$85.91M | +43.34% |
| 2022 | $198.20M | +$95.16M | +92.34% |
| 2021 | $103.04M | +$101.82M | +8297.22% |
TTM Growth
N/A
3-Year CAGR
+19.80%
5-Year CAGR
+229.68%
